Kapil Arya

Sourced from institutional research profiles (UAMS TRI or ARA).

M.D.

UAMS

Also affiliated: Arkansas Children's Hospital (2018–2026); State University of New York (2016); Jordan University of Science and Technology (2026); SUNY Downstate Health Sciences University (2016–2017); Columbia University Irving Medical Center (2024); University of Arkansas Medical Center (2018–2020); King Abdullah University Hospital (2026); Cure Spinal Muscular Atrophy (2024); Govind Ballabh Pant Hospital (2012); University of Colorado Anschutz (2024); Columbia University (2024); The University of Texas Southwestern Medical Center (2026)

11 h-index 40 pubs 600 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website UAMS TRI Profile

Edit your profile

OverviewAI-generated summary

Kapil Arya's research focuses on the synthesis and screening of novel chemical compounds for potential therapeutic applications, particularly in antifungal and antitubercular contexts. His work has explored microwave-assisted and solvent-free synthetic methods, emphasizing green chemistry approaches. Arya has also investigated compounds for cytotoxic activity and their potential in cancer treatment. His recent publications include work on combination molecular therapies for type 1 spinal muscular atrophy and a case series on thrombotic microangiopathy following treatment for this condition. Arya's scholarly contributions are reflected in his h-index of 11 and over 600 citations across 40 publications. He collaborates with researchers at the University of Arkansas for Medical Sciences, including Aravindhan Veerapandiyan, Aravindhan Veerapaniyan, Abhilash Thatikala, and Praveen Kumar Ramani.

Metrics

h-index: 11
Publications: 40
Citations: 600

Positions

M.D. publications 2018–2026

University of Arkansas for Medical Sciences Institution web page

Selected Publications

GAD65 Antibody–Associated Epilepsy and Autoimmune Encephalitis in Children and Young Adults: A Single-Center Case Series and Review of Literature (2026)

Journal of Child Neurology DOI OpenAlex
Expanding the Genotypic Spectrum of SLC18A2 Mutation–Related Disorder—A Novel Mutation and Review of Literature (2026)

Journal of Child Neurology DOI OpenAlex
CACNA1A Channelopathies and Associated Eye Movement Disorders (2026)

Contemporary clinical neuroscience DOI OpenAlex
Essential Components of Child Neurology Training: Program Director Consensus Recommendations (2025)

Annals of the Child Neurology Society 4 citations DOI OpenAlex
Outcomes of early‐treated infants with spinal muscular atrophy: A multicenter, retrospective cohort study (2024)

Muscle & Nerve 14 citations DOI OpenAlex
Considerations for Treatment in Clinical Care of Spinal Muscular Atrophy Patients (2024)

Children 6 citations DOI OpenAlex
Arthur L. Rose, M.D.(1932-2022): A Requiem (2023)

Pediatric Neurology DOI OpenAlex
An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy (2022)

Annals of Clinical and Translational Neurology 36 citations DOI OpenAlex
Frequency, Predictors, and Outcome of Seizures in Patients With Myelomeningocele: Single-Center Retrospective Cohort Study (2021)

Journal of Child Neurology 6 citations DOI OpenAlex
Thrombotic Microangiopathy Following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series (2020)

The Journal of Pediatrics 206 citations DOI OpenAlex
Combination molecular therapies for type 1 spinal muscular atrophy (2020)

Muscle & Nerve 80 citations DOI OpenAlex
BAG3 Myopathy Presenting With Prominent Neuropathic Phenotype and No Cardiac or Respiratory Involvement: A Case Report and Literature Review (2020)

Journal of Clinical Neuromuscular Disease 6 citations DOI OpenAlex
Spinal muscular atrophy care in the COVID‐19 pandemic era (2020)

Muscle & Nerve 37 citations DOI OpenAlex
Electroclinical findings of SYNJ1 epileptic encephalopathy (2020)

Journal of Pediatric Neurosciences 10 citations DOI OpenAlex
Reflex Photosensitive Epilepsy (2019)

Journal of Pediatric Epilepsy DOI OpenAlex